EPS Creative Health Technology Group Limited (03860) announced its monthly return for the period ended 30 November 2025. The authorized share capital remained at 1,000,000,000 ordinary shares with a par value of HKD0.01 each, totaling HKD10,000,000. The issued share capital also remained unchanged at 522,177,419 shares with no treasury shares reported.

According to the share option scheme adopted on 31 May 2017 at an exercise price of HKD0.60, 200,000 share options lapsed during the period, reducing the outstanding share options from 5,400,000 to 5,200,000. No new shares were issued, and no treasury shares were utilized.

Under the Sale and Purchase Agreement dated 28 March 2023, a maximum of 100,000,000 consideration shares can be issued at an initial price of HKD1 per share. No issuance occurred during the reporting month. There were no other share movements, leaving the overall share capital figures unchanged at the end of November 2025.